167 related articles for article (PubMed ID: 8548767)
1. Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in primary prostate cancer.
Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Zhang W; Kapusta LR; Slingerland JM; Klotz LH
Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
[TBL] [Abstract][Full Text] [Related]
4. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
7. Detection of telomerase activity in prostate cancer by needle biopsy.
Takahashi C; Miyagawa I; Kumano S; Oshimura M
Eur Urol; 1997; 32(4):494-8. PubMed ID: 9412813
[TBL] [Abstract][Full Text] [Related]
8. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
[TBL] [Abstract][Full Text] [Related]
9. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
[TBL] [Abstract][Full Text] [Related]
11. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
14. Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
Oncol Rep; 2002; 9(3):545-9. PubMed ID: 11956625
[TBL] [Abstract][Full Text] [Related]
15. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
16. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
17. Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.
Athanassiadou P; Bantis A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Giannopoulos A
J Exp Clin Cancer Res; 2003 Dec; 22(4):613-8. PubMed ID: 15053304
[TBL] [Abstract][Full Text] [Related]
18. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
Wullich B; Rohde V; Oehlenschläger B; Bonkhoff H; Ketter R; Zwergel T; Sattler HP
J Urol; 1999 Jun; 161(6):1997-2001. PubMed ID: 10332489
[TBL] [Abstract][Full Text] [Related]
19. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
20. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
